Literature DB >> 8570024

Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord.

H Teoh1, L J Fowler, N G Bowery.   

Abstract

The novel anti-epileptic, lamotrigine (LTG) has been shown to exhibit antinociceptive effects in the rat. In the present study, the effect of LTG on the electrically-evoked release of endogenous amino acids from rat isolated spinal dorsal horn slices with intact dorsal roots has been examined and compared with those of morphine in the same preparation. LTG (0.1-300 microM) inhibited the release of aspartate, glutamate and GABA in a concentration-dependent manner. The lowest concentrations of morphine (0.001-0.01 microM) enhanced the stimulated release of aspartate and glutamate while the higher concentrations inhibited their release. Stimulated GABA release was reduced in a concentration-dependent manner. The anticonvulsant was more potent at inhibiting the release of glutamate (IC50 = 20 microM) than that of GABA (IC50 = 44 microM) supporting the previous suggestion that lamotrigine is a selective inhibitor of glutamate release. This suggests that the reduction in glutamate release could be one of the mechanisms by which lamotrigine exerts its antinociceptive effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570024     DOI: 10.1016/0028-3908(95)00104-e

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus.

Authors:  Giuseppe Tringali; Jean Michel Aubry; Pierluigi Navarra; Giacomo Pozzoli
Journal:  Psychopharmacology (Berl)       Date:  2006-09-01       Impact factor: 4.530

Review 2.  Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets.

Authors:  Michele Ferrante; Kim T Blackwell; Michele Migliore; Giorgio A Ascoli
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 3.  Glutamatergic medications for the treatment of drug and behavioral addictions.

Authors:  M Foster Olive; Richard M Cleva; Peter W Kalivas; Robert J Malcolm
Journal:  Pharmacol Biochem Behav       Date:  2011-04-22       Impact factor: 3.533

4.  GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists.

Authors:  H Teoh; M Malcangio; N G Bowery
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release.

Authors:  Sudarat Nimitvilai; Melissa Herman; Chang You; Devinder S Arora; Maureen A McElvain; Marisa Roberto; Mark S Brodie
Journal:  Neuropharmacology       Date:  2014-03-19       Impact factor: 5.250

Review 6.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

7.  Comparison of antinociceptive effect of the antiepileptic drug gabapentin to that of various dosage combinations of gabapentin with lamotrigine and topiramate in mice and rats.

Authors:  Keshab Raj Paudel; Sk Bhattacharya; Gp Rauniar; Bp Das
Journal:  J Neurosci Rural Pract       Date:  2011-07

8.  Anticonvulsant drugs in bipolar disorder.

Authors:  H Grunze; S Schlösser; B Amann; J Walden
Journal:  Dialogues Clin Neurosci       Date:  1999-06       Impact factor: 5.986

9.  Intrathecal lamotrigine attenuates mechanical allodynia and suppresses microglial and astrocytic activation in a rat model of spinal nerve ligation.

Authors:  Yun-Sik Choi; In-Gu Jun; Sung-Hoon Kim; Jong-Yeon Park
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.